216 related articles for article (PubMed ID: 32843330)
1. Successful Prediction of Positron Emission Tomography-Imaged Metformin Hepatic Uptake Clearance in Humans Using the Quantitative Proteomics-Informed Relative Expression Factor Approach.
Sachar M; Kumar V; Gormsen LC; Munk OL; Unadkat JD
Drug Metab Dispos; 2020 Nov; 48(11):1210-1216. PubMed ID: 32843330
[TBL] [Abstract][Full Text] [Related]
2. Prediction of Transporter-Mediated Rosuvastatin Hepatic Uptake Clearance and Drug Interaction in Humans Using Proteomics-Informed REF Approach.
Kumar V; Yin M; Ishida K; Salphati L; Hop CECA; Rowbottom C; Xiao G; Lai Y; Mathias A; Chu X; Humphreys WG; Liao M; Nerada Z; Szilvásy N; Heyward S; Unadkat JD
Drug Metab Dispos; 2021 Feb; 49(2):159-168. PubMed ID: 33051248
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Hepatic Transporter Tissue Expression in Rodents and Interspecies Hepatic OCT1 Activity.
Morse BL; Fallon JK; Kolur A; Hogan AT; Smith PC; Hillgren KM
AAPS J; 2021 Apr; 23(3):58. PubMed ID: 33903987
[TBL] [Abstract][Full Text] [Related]
4. Successful Prediction of In Vivo Hepatobiliary Clearances and Hepatic Concentrations of Rosuvastatin Using Sandwich-Cultured Rat Hepatocytes, Transporter-Expressing Cell Lines, and Quantitative Proteomics.
Ishida K; Ullah M; Tóth B; Juhasz V; Unadkat JD
Drug Metab Dispos; 2018 Jan; 46(1):66-74. PubMed ID: 29084782
[TBL] [Abstract][Full Text] [Related]
5. Successful Prediction of Human Hepatic Concentrations of Transported Drugs Using the Proteomics-Informed Relative Expression Factor Approach.
Yin M; Balhara A; Marie S; Tournier N; Gáborik Z; Unadkat JD
Clin Pharmacol Ther; 2024 Mar; 115(3):595-605. PubMed ID: 38037845
[TBL] [Abstract][Full Text] [Related]
6. Prediction of Hepatobiliary Clearances and Hepatic Concentrations of Transported Drugs in Humans Using Rosuvastatin as a Model Drug.
Storelli F; Li CY; Sachar M; Kumar V; Heyward S; Sáfár Z; Kis E; Unadkat JD
Clin Pharmacol Ther; 2022 Sep; 112(3):593-604. PubMed ID: 35152400
[TBL] [Abstract][Full Text] [Related]
7. Clinical CYP3A inhibitor alternatives to ketoconazole, clarithromycin and itraconazole, are not transported into the liver by hepatic organic anion transporting polypeptides and organic cation transporter 1.
Higgins JW; Ke AB; Zamek-Gliszczynski MJ
Drug Metab Dispos; 2014 Nov; 42(11):1780-4. PubMed ID: 25106415
[TBL] [Abstract][Full Text] [Related]
8. Comparison of In Vitro to In Vivo Extrapolation Approaches for Predicting Transporter-Mediated Hepatic Uptake Clearance Using Suspended Rat Hepatocytes.
Li N; Badrinarayanan A; Li X; Roberts J; Hayashi M; Virk M; Gupta A
Drug Metab Dispos; 2020 Oct; 48(10):861-872. PubMed ID: 32759366
[TBL] [Abstract][Full Text] [Related]
9. Prediction of organic anion-transporting polypeptide 1B1- and 1B3-mediated hepatic uptake of statins based on transporter protein expression and activity data.
Kunze A; Huwyler J; Camenisch G; Poller B
Drug Metab Dispos; 2014 Sep; 42(9):1514-21. PubMed ID: 24989890
[TBL] [Abstract][Full Text] [Related]
10. Albumin-Mediated Uptake Improves Human Clearance Prediction for Hepatic Uptake Transporter Substrates Aiding a Mechanistic In Vitro-In Vivo Extrapolation (IVIVE) Strategy in Discovery Research.
Li N; Badrinarayanan A; Ishida K; Li X; Roberts J; Wang S; Hayashi M; Gupta A
AAPS J; 2020 Nov; 23(1):1. PubMed ID: 33196949
[TBL] [Abstract][Full Text] [Related]
11. Physiologically Based Pharmacokinetic Modeling of Transporter-Mediated Hepatic Clearance and Liver Partitioning of OATP and OCT Substrates in Cynomolgus Monkeys.
Morse BL; MacGuire JG; Marino AM; Zhao Y; Fox M; Zhang Y; Shen H; Griffith Humphreys W; Marathe P; Lai Y
AAPS J; 2017 Nov; 19(6):1878-1889. PubMed ID: 29019117
[TBL] [Abstract][Full Text] [Related]
12. Interaction of oral antidiabetic drugs with hepatic uptake transporters: focus on organic anion transporting polypeptides and organic cation transporter 1.
Bachmakov I; Glaeser H; Fromm MF; König J
Diabetes; 2008 Jun; 57(6):1463-9. PubMed ID: 18314419
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory Effects of Green Tea and (-)-Epigallocatechin Gallate on Transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-Glycoprotein.
Knop J; Misaka S; Singer K; Hoier E; Müller F; Glaeser H; König J; Fromm MF
PLoS One; 2015; 10(10):e0139370. PubMed ID: 26426900
[TBL] [Abstract][Full Text] [Related]
14. Quantitation of Plasma Membrane Drug Transporters in Kidney Tissue and Cell Lines Using a Novel Proteomic Approach Enabled a Prospective Prediction of Metformin Disposition.
Kikuchi R; Chiou WJ; Durbin KR; Savaryn JP; Ma J; Emami Riedmaier A; de Morais SM; Jenkins GJ; Bow DAJ
Drug Metab Dispos; 2021 Oct; 49(10):938-946. PubMed ID: 34330717
[TBL] [Abstract][Full Text] [Related]
15. Differences in Metformin and Thiamine Uptake between Human and Mouse Organic Cation Transporter 1: Structural Determinants and Potential Consequences for Intrahepatic Concentrations.
Meyer MJ; Tuerkova A; Römer S; Wenzel C; Seitz T; Gaedcke J; Oswald S; Brockmöller J; Zdrazil B; Tzvetkov MV
Drug Metab Dispos; 2020 Dec; 48(12):1380-1392. PubMed ID: 33037045
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in preclinical in vitro approaches towards quantitative prediction of hepatic clearance and drug-drug interactions involving organic anion transporting polypeptide (OATP) 1B transporters.
Nozaki Y; Izumi S
Drug Metab Pharmacokinet; 2020 Feb; 35(1):56-70. PubMed ID: 31901416
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of Organic Cation Transporter 1 (OCT1) Substrates in Oct1/2 Knockout Mice and Species Difference in Hepatic OCT1-Mediated Uptake.
Morse BL; Kolur A; Hudson LR; Hogan AT; Chen LH; Brackman RM; Sawada GA; Fallon JK; Smith PC; Hillgren KM
Drug Metab Dispos; 2020 Feb; 48(2):93-105. PubMed ID: 31771949
[TBL] [Abstract][Full Text] [Related]
18. Extrapolation of the Hepatic Clearance of Drugs in the Absence of Albumin In Vitro to That in the Presence of Albumin In Vivo: Comparative Assessement of 2 Extrapolation Models Based on the Albumin-Mediated Hepatic Uptake Theory and Limitations and Mechanistic Insights.
Poulin P; Haddad S
J Pharm Sci; 2018 Jul; 107(7):1791-1797. PubMed ID: 29567347
[TBL] [Abstract][Full Text] [Related]
19. Hepatic Transporter Alterations by Nuclear Receptor Agonist T0901317 in Sandwich-Cultured Human Hepatocytes: Proteomic Analysis and PBPK Modeling to Evaluate Drug-Drug Interaction Risk.
Ito K; Sjöstedt N; Malinen MM; Guo C; Brouwer KLR
J Pharmacol Exp Ther; 2020 May; 373(2):261-268. PubMed ID: 32127372
[TBL] [Abstract][Full Text] [Related]
20. Organic Cation Transporter 1 Is Responsible for Hepatocellular Uptake of the Tyrosine Kinase Inhibitor Pazopanib.
Ellawatty WEA; Masuo Y; Fujita KI; Yamazaki E; Ishida H; Arakawa H; Nakamichi N; Abdelwahed R; Sasaki Y; Kato Y
Drug Metab Dispos; 2018 Jan; 46(1):33-40. PubMed ID: 29089306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
